Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Bryce Lund

34 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 18 Receptor Pharmacology 10 Clinical Trial 9 Anxiety 7 Mechanism of Action 7 Review Article 7 Safety 7 Neuroplasticity 6 Pharmacology 6 Addiction 6 Randomized Controlled Trial 5 Animal Study 5

Journals

ClinicalTrials.gov 4 Translational psychiatry 3 European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 2 Neuroscience applied 2 European journal of pharmacology 1 Neuropsychopharmacology 1 Schizophrenia research 1 Molecular psychiatry 1

Publication history

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.European journal of pharmacology · 2026-08-11 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15 CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorderNeuropsychopharmacology · 2026-07-07 Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.Schizophrenia research · 2026-06-01 Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Molecular psychiatry · 2026-05-29 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15 Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09 Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09 Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacinNeuroscience Applied · 2026-01-01 Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01 Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeClinicalTrials.gov · 2025-11-25 Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2025-11-06 Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01 Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-04-10 630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-09 Effects of Psilocybin in Advanced-Stage Cancer Patients With AnxietyClinicalTrials.gov · 2025-03-13 The Epidemiology of Psychedelic Use Among United States Military VeteransJournal of Psychoactive Drugs · 2024-09-12 [Psychedelic psychiatry].Lakartidningen · 2024-04-04 A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventionsJournal of Psychedelic Studies · 2024-04-02 MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brainResearch Square · 2024-01-12 Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01 Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01 The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10 Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stabilityZenodo (CERN European Organization for Nuclear Research) · 2023-01-01 Magic mushroom extracts in lipid membranes.Biochimica et biophysica acta. Biomembranes · 2022-09-01 Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2022-08-11 A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.The international journal of neuropsychopharmacology · 2021-09-21 A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain.International journal of molecular sciences · 2021-01-15 Effects of a single dose of psilocybin on behaviour, brain 5-HT receptor occupancy and gene expression in the pig.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2021-01-01 Trip Reports: Exploring the Experience of Psychedelic IntoxicationLund University Publications (Lund University) · 2020-12-31 P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-11-01 Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-GlucuronosyltransferasesDrug Metabolism and Disposition · 2010-03-01

Author directory